Francois Cedric

Insider·Apellis Pharmaceuticals, Inc.·APLS·Insider since 2025·Form 4 filings: 10
Trades YTD
3
Trades (12m)
6
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

6 transactions
22 Jan 2026
SOLD
$APLS
27,192
$21.77
S
20 Jan 2026
SOLD
$APLS
8,182
$19.79
S
13 Jan 2026
SOLD
$APLS
10,186
$22.19
S
17 Jul 2025
SOLD
$APLS
19,725
$20.21
S
15 Jul 2025
SOLD
$APLS
1,900
$20.09
S
14 Jul 2025
SOLD
$APLS
137,465
$20.19
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Apellis Pharmaceuticals, Inc.

last 30 days

No active insider cluster at Apellis Pharmaceuticals, Inc. in the last 30 days. Cedric's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Cedric is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 10:37 UTC.